Search

Your search keyword '"Comi, G"' showing total 5,491 results

Search Constraints

Start Over You searched for: Author "Comi, G" Remove constraint Author: "Comi, G"
5,491 results on '"Comi, G"'

Search Results

4. Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial

8. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

10. P120 Refining MRI pattern in sarcoglycanopathies: upper body pattern and new approaches to assess disease progression

14. Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients with Primary Progressive Multiple Sclerosis

15. The agenda of the global patient reported outcomes for multiple sclerosis (PROMS) initiative: Progresses and open questions

16. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

20. Locus for severity implicates CNS resilience in progression of multiple sclerosis

21. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

22. Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study

23. Correction to: Risdiplam in Patients Previously Treated with Other Therapies for Spinal Muscular Atrophy: An Interim Analysis from the JEWELFISH Study (Neurology and Therapy, (2023), 12, 2, (543-557), 10.1007/s40120-023-00444-1)

24. Clinical Phenotype of Pediatric and Adult Patients With Spinal Muscular Atrophy With Four SMN2 Copies: Are They Really All Stable?

26. Signs and symptoms of COVID-19 in patients with multiple sclerosis

27. Givinostat in Duchenne Muscular Dystrophy: Effect on Disease Milestones.

28. Revisiting mitochondrial ocular myopathies: a study from the Italian Network

33. O.13 Givinostat in DMD: results of the Epidys Study

36. Role of B Cells in Multiple Sclerosis and Related Disorders

37. Author Correction: Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (Nature Genetics, (2021), 53, 12, (1636-1648), 10.1038/s41588-021-00973-1)

38. The risk of infection in patients with multiple sclerosis treated with disease-modifying therapies: A Delphi consensus statement

39. Vaccinations in patients with multiple sclerosis: A Delphi consensus statement

40. An Investigation of the Role of Common and Rare Variants in a Large Italian Multiplex Family of Multiple Sclerosis Patients

41. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

42. Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis

44. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis

45. Critical Review of Existing Trials

46. Neurophysiology

50. Cost-Effectiveness Analysis of Cannabinoid Oromucosal Spray Use for the Management of Spasticity in Subjects with Multiple Sclerosis

Catalog

Books, media, physical & digital resources